The cost of the bivalent cervical cancer vaccine costs about $600 per dose, and a total of three doses are required to be administered within one year. The bivalent cervical cancer vaccine mainly prevents HPV type 16 and HPV type 18 infection in clinical practice, and the main cause of cervical cancer in Asian women is caused by persistent infection with HPV type 16 or HPV type 18, so it is still necessary to receive the cervical cancer vaccine. The higher the price of cervical cancer vaccine, the more effective it is in preventing cervical cancer. For example, the nine-valent vaccine can clinically block about 92% or more of cervical, vaginal, vulvar and anal cancers, so it should be considered carefully before receiving the cervical cancer vaccine.